Post hoc analyses explored the impact of semaglutide across an array of conditions including obstructive sleep apnea (OSA), asthma-related adverse outcomes, liver health, cardiometabolic...
COPENHAGEN, Denmark, July 7, 2025 /PRNewswire/ -- CathVision ApS, a medical technology company developing electrophysiology solutions for cardiac ablation, announces the market release of...